Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
BSF Enterprise: Grant of Options. Watch the RNS video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Who knows but probably at this rate. It's being heavily traded at the moment so when we move to 13p+ we just get hit by sells and move back to the 11p area again.
Mcap is crazy low with what is going on behind the scenes but just need to be patient and wait for company defining news.
Do you think by the time a big piece of news comes along it will still be at 11p?
Agreed jabberba as an investor Im happy with that endorsement. My biggest concern about this field is that it is so competitive, so being singled out for a development grant is a big deal
So we get awarded a grant of over £500,000 and yet not a single buy.
There is defo no love for BSFA at the moment. Looks like will only take a BIG piece of news to get this moving north again, could do with one of these PoC company names being released, that would cause a stir.
Bsfa pretty pleased as they should be. Endorsement as well as the money is the big story!
https://twitter.com/BSF_Enterprise/status/1703657606890262908?t=N_rD6Msh7DFglyBs6OLDIw&s=19
Good to see confirmation of the grant. A sum of €612,000 is pretty substantial and will go a long way towards strategic goals recently set out.
Well done bsfa.
The RNS about the €100,000 grant from 27 October last year: https://www.lse.co.uk/rns/BSFA/3d-bio-tissues-receives-8364100000-grant-zzppyhqfigh2xnr.html
This seems to be about a year old with "Winners ... invited to attend a Community Dinner at the EIT Food Venture Summit 2022 in Lisbon on October 26th"
https://www.eitfood.eu/projects/prize-based-challenge/cultivated-meat-innovation-challenge
Each of the 4 winners are awarded €100,000, opening the possibility for further substantial funding by EIT Food to develop their project.
For BSFA/3DBT: City-mix™ Cell-Boosters and Thermostable Growth Factors (UK) - “3DBio-Tissues will combine its unique food-grade City-mix™ supplements with Qkine’s world-leading, highly thermostable growth factors to maximise effectiveness of animal-free culture media, reduce reliance on other protein components, and accelerate commercialisation at lower costs.”
So maybe 4 initial winners with 3 now to receive further funding? No mention of this award on any of the 3 companies or EIT Food websites but there has clearly been a press release because several news sites are covering exactly the same details.
Maybe the company should also start to look at further avenues. I.E the Clit and the Gates foundation as this could really bring them world coverage.inmv
Bought back in this morning at 11.42p (showing as a sell on LSE). This is my ISA. My holding outside of tax wrappers hasn't been touched.
Maybe no one's told them they'd got the grant, or they've been too busy to check their email?
For those concerned is another placing on way . this award money might help to reduce risk of a placing .
Best news I've heard in a while on this share. received a grant in an ultra competitive sector and hailed as cutting edge in their field. Wont be selling anytime soon
I'm surprised not been one this morning but sure it will come either later today or Monday.
Where's the RNS???
BSFS awarded share of €1.8 million EIT food grant today with 2 other companies. Expecting RNS tomorrow.
https://tech.eu/2023/09/14/eit-food-grants-eur18m-to-three-companies-for-cultivated-meat-innovation/
It's certainly lost the wind from its sails. Nothing new to really say for the whole summer, just a washy RNS.
Pumpers are out on twitter, washy RNS light on detail. Smells like a placing incoming
To be fair, you've only been here 5 minutes
Purchasers picking up shares after dip .
My guess soon move up again . different views on lab grown meat .skip first 11 minutes
https://www.youtube.com/live/fFC_bMwteOY?feature=shared . Some more sells today .Others might see this an opportunity to top up .
Yep, another none RNS that seems to have caused more loss of interest this morning, looking at the fall in SP atm.
Che Connon, Chief Executive of 3DBT and Managing Director of BSF, said: "BSF has made huge progress in its first year as a listed company, with 3D Bio-Tissues achieving significant technical and commercial milestones. We have a clear plan and are well funded to continue this momentum in the coming year by increasing sales and driving the development of our flagship City-Mix™ product. We intend to add additional growth through the creation of a collaborative ecosystem of tissue engineering companies, through M&A and partnerships, and we are extremely excited about the opportunities this will afford us as we continue to grow our commercial presence across the industry."
I’d hazard a guess the initial feedback hasn’t been great, based on this comment;
3DBT will continue its product development programme for City-Mix™ with a particular focus on improving the thickness and density of each end product. This is in order to address key objectives for its respective markets, including enhancing the taste and texture of cultivated meat products and developing the thickness and size of its cultivated leather products.